Smith, Moore & Co’s Harte-Hanks HHS Stock Holding History
Bought
Maintained
Sold
Other funds holding HHS
FM
EVC
VCA
CS
BCM
Smith, Moore & Co's HHS Position: Q1 2019 in Review
Smith, Moore & Co sold out of Harte-Hanks (HHS) in Q1 2019, closing a stake of 10,000 shares — an estimated $24K sold.
Smith, Moore & Co first reported a position in HHS in Q3 2017 and held it in 6 quarters. The position peaked at $111K in Q2 2018. 22 funds tracked by Wall St. Rank hold HHS as of Q1 2019.
- Smith, Moore & Co reported no remaining Harte-Hanks position as of Q1 2019 after selling out during the quarter.
- Smith, Moore & Co sold 10,000 Harte-Hanks shares in Q1 2019, an estimated $24K.
- Smith, Moore & Co first reported a position in Harte-Hanks in Q3 2017 and held it in 6 quarters.
- Smith, Moore & Co's Harte-Hanks position peaked at $111K in Q2 2018.
- 22 funds tracked by Wall St. Rank held Harte-Hanks as of Q1 2019.
Based on Smith, Moore & Co's 13F filing for Q1 2019, filed 7 May 2019.